Cargando…
Tailoring the AIE Chromogen 2-(2-Hydroxyphenyl)benzothiazole for Use in Enzyme-Triggered Molecular Brachytherapy
A targeted strategy for treating cancer is antibody-directed enzyme prodrug therapy, where the enzyme attached to the antibody causes conversion of an inactive small-molecule prodrug into an active drug. A limitation may be the diffusion of the active drug away from the antibody target site. A relat...
Autores principales: | Wu, Zhiyuan, Dou, Jinghuai, Nguyen, Kathy-Uyen, Eppley, Jayden C., Siwawannapong, Kittipan, Zhang, Yunlong, Lindsey, Jonathan S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9786593/ https://www.ncbi.nlm.nih.gov/pubmed/36557815 http://dx.doi.org/10.3390/molecules27248682 |
Ejemplares similares
-
2-(2-Hydroxyphenyl)-1,3-benzothiazole-6-carbaldehyde
por: Chen, Kew-Yu, et al.
Publicado: (2011) -
Red-Shift (2-Hydroxyphenyl)-Benzothiazole Emission by Mimicking the Excited-State Intramolecular Proton Transfer Effect
por: Ren, Yong, et al.
Publicado: (2021) -
N-(4-Hydroxyphenyl)-2-(1,1,3-trioxo-2,3-dihydro-1,2-benzothiazol-2-yl)acetamide
por: Verma, Abha, et al.
Publicado: (2009) -
Aggregation tailored emission of a benzothiazole based derivative: photostable turn on bioimaging
por: Kaur, Ishpreet, et al.
Publicado: (2019) -
De novo design of a novel AIE fluorescent probe tailored to autophagy visualization via pH manipulation
por: Huang, Xueyan, et al.
Publicado: (2023)